Key Details
Price
$7.82Annual ROE
18.68%Beta
1.06Events Calendar
Next earnings date:
May 6, 2025Recent quarterly earnings:
Feb 24, 2025Recent annual earnings:
Feb 24, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Mar 3, 25 Citizens Capital Markets
Market OutperformFeb 25, 25 RBC Capital
OutperformFeb 25, 25 HC Wainwright & Co.
BuyFeb 25, 25 Citizens Capital Markets
Market OutperformJan 31, 25 JMP Securities
Market OutperformJan 13, 25 Needham
BuyJan 13, 25 Evercore ISI Group
OutperformDec 17, 24 Needham
BuyNov 5, 24 RBC Capital
OutperformNov 5, 24 Needham
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
BioCryst Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for BioCryst Pharmaceuticals?
- Does BioCryst Pharmaceuticals pay dividends?
- What sector is BioCryst Pharmaceuticals in?
- What industry is BioCryst Pharmaceuticals in?
- What country is BioCryst Pharmaceuticals based in?
- When did BioCryst Pharmaceuticals go public?
- Is BioCryst Pharmaceuticals in the S&P 500?
- Is BioCryst Pharmaceuticals in the NASDAQ 100?
- Is BioCryst Pharmaceuticals in the Dow Jones?
- When was BioCryst Pharmaceuticals's last earnings report?
- When does BioCryst Pharmaceuticals report earnings?
- Should I buy BioCryst Pharmaceuticals stock now?
What is the ticker symbol for BioCryst Pharmaceuticals?
The ticker symbol for BioCryst Pharmaceuticals is NASDAQ:BCRX
Does BioCryst Pharmaceuticals pay dividends?
No, BioCryst Pharmaceuticals does not pay dividends
What sector is BioCryst Pharmaceuticals in?
BioCryst Pharmaceuticals is in the Healthcare sector
What industry is BioCryst Pharmaceuticals in?
BioCryst Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry
What country is BioCryst Pharmaceuticals based in?
BioCryst Pharmaceuticals is headquartered in United States
When did BioCryst Pharmaceuticals go public?
BioCryst Pharmaceuticals's initial public offering (IPO) was on March 4, 1994
Is BioCryst Pharmaceuticals in the S&P 500?
No, BioCryst Pharmaceuticals is not included in the S&P 500 index
Is BioCryst Pharmaceuticals in the NASDAQ 100?
No, BioCryst Pharmaceuticals is not included in the NASDAQ 100 index
Is BioCryst Pharmaceuticals in the Dow Jones?
No, BioCryst Pharmaceuticals is not included in the Dow Jones index
When was BioCryst Pharmaceuticals's last earnings report?
BioCryst Pharmaceuticals's most recent earnings report was on Feb 24, 2025
When does BioCryst Pharmaceuticals report earnings?
The next expected earnings date for BioCryst Pharmaceuticals is May 6, 2025
Should I buy BioCryst Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions